Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
SAN DIEGO, Aug. 31, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:
|
Stifel Nicolaus 2011 Healthcare Conference |
||
Date: |
Wednesday, September 7, 2011 |
||
Time: |
1:30pm Eastern Time (10:30am Pacific Time) |
||
Place: |
Four Seasons Hotel in Boston |
||
Speaker: |
Scott Byrd, SVP & Chief Commercial Officer |
||
|
UBS Global Life Sciences Conference |
||
Date: |
Tuesday, September 20, 2011 |
||
Time: |
11:30am Eastern Time (8:30am Pacific Time) |
||
Place: |
Grand Hyatt Hotel in New York City |
||
Speaker: |
Ted Schroeder, President & CEO |
||
|
JMP Securities Healthcare Conference |
||
Date: |
Wednesday, September 28, 2011 |
||
Time: |
9:30am Eastern Time (6:30am Pacific Time) |
||
Place: |
The St. Regis Hotel in New York City |
||
Speaker: |
Ted Schroeder, President & CEO |
||
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.
Contacts: |
William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400 |
|
SOURCE Cadence Pharmaceuticals, Inc.
Share this article